Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

2.

Changes in cell adhesivity and cytoskeleton-related proteins during imatinib-induced apoptosis of leukemic JURL-MK1 cells.

Kuželová K, Pluskalová M, Grebeňová D, Pavlásková K, Halada P, Hrkal Z.

J Cell Biochem. 2010 Dec 15;111(6):1413-25. doi: 10.1002/jcb.22868.

PMID:
20830748
3.

Suberoylanilide hydroxamic acid (SAHA) at subtoxic concentrations increases the adhesivity of human leukemic cells to fibronectin.

Kuzelová K, Pluskalová M, Brodská B, Otevrelová P, Elknerová K, Grebenová D, Hrkal Z.

J Cell Biochem. 2010 Jan 1;109(1):184-95. doi: 10.1002/jcb.22397.

PMID:
19911379
4.

Isoform-specific cleavage of 14-3-3 proteins in apoptotic JURL-MK1 cells.

Kuzelová K, Grebenová D, Pluskalová M, Kavan D, Halada P, Hrkal Z.

J Cell Biochem. 2009 Mar 1;106(4):673-81. doi: 10.1002/jcb.22061.

PMID:
19173300
5.

Rho-signaling pathways in chronic myelogenous leukemia.

Kuzelová K, Hrkal Z.

Cardiovasc Hematol Disord Drug Targets. 2008 Dec;8(4):261-7. Review.

PMID:
19075636
7.

Mean diameter of nucleolar bodies in cultured human leukemic myeloblasts is mainly related to the S and G2 phase of the cell cycle.

Smetana K, Kuzelova K, Zápotocký M, Starková J, Hrkal Z, Trka J.

Eur J Histochem. 2007 Oct-Dec;51(4):269-74.

PMID:
18162456
10.

The proteomic study of sodium butyrate antiproliferative/cytodifferentiation effects on K562 cells.

Grebenová D, Kuzelová K, Pluskalová M, Peslová G, Halada P, Hrkal Z.

Blood Cells Mol Dis. 2006 Nov-Dec;37(3):210-7. Epub 2006 Sep 15.

PMID:
16978890
11.

On the nucleolar size and density in human early granulocytic progenitors, myeloblasts.

Smetana K, Klamová H, Mikulenková D, Pluskalová M, Hrkal Z.

Eur J Histochem. 2006 Apr-Jun;50(2):119-24.

PMID:
16864122
12.

Photodynamic treatment (ALA-PDT) suppresses the expression of the oncogenic Bcr-Abl kinase and affects the cytoskeleton organization in K562 cells.

Pluskalová M, Peslová G, Grebenová D, Halada P, Hrkal Z.

J Photochem Photobiol B. 2006 Jun 1;83(3):205-12. Epub 2006 Feb 21.

PMID:
16495075
13.

Intranucleolar translocation of AgNORs in early granulocytic precursors in chronic myeloid leukaemia and K 562 cells.

Smetana K, Klamová H, Pluskalová M, Stöckbauer P, Jirásková I, Hrkal Z.

Folia Biol (Praha). 2005;51(4):89-92.

14.

To the intranucleolar translocation of AgNORs in leukemic early granulocytic and plasmacytic precursors.

Smetana K, Klamová H, Pluskalová M, Stöckbauer P, Hrkal Z.

Histochem Cell Biol. 2006 Jan;125(1-2):165-70. Epub 2005 Sep 2.

PMID:
16142449
15.

Fast apoptosis and erythroid differentiation induced by imatinib mesylate in JURL-MK1 cells.

Kuzelová K, Grebenová D, Marinov I, Hrkal Z.

J Cell Biochem. 2005 May 15;95(2):268-80.

PMID:
15770664
16.
17.

A short note on the nucleolar size and density in apoptotic leukemic granulocytic precursors (HL-60 cells).

Smetana K, Chan PK, Marinov Y, Soucek J, Hrkal Z, Busch H.

Life Sci. 2004 Jul 2;75(7):791-6.

PMID:
15183072
19.

Interferon-alpha suppresses proliferation of chronic myelogenous leukemia cells K562 by extending cell cycle S-phase without inducing apoptosis.

Grebenová D, Kuzelová K, Fuchs O, Halada P, Havlícek V, Marinov I, Hrkal Z.

Blood Cells Mol Dis. 2004 Jan-Feb;32(1):262-9.

PMID:
14757443
20.

Early apoptotic features of K562 cell death induced by 5-aminolaevulinic acid-based photodynamic therapy.

Kuzelová K, Grebenová D, Pluskalová M, Marinov I, Hrkal Z.

J Photochem Photobiol B. 2004 Jan 23;73(1-2):67-78.

PMID:
14732253
21.

On the way to functional genomics.

Hrkal Z.

Sb Lek. 2003;104(2):217-22.

PMID:
14577131
22.
23.

Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by 5-aminolevulinic acid-based photodynamic therapy in HL60 leukemia cells.

Grebenová D, Kuzelová K, Smetana K, Pluskalová M, Cajthamlová H, Marinov I, Fuchs O, Soucek J, Jarolím P, Hrkal Z.

J Photochem Photobiol B. 2003 Feb;69(2):71-85.

PMID:
12633980
24.

[Use of photodynamic therapy for elimination of residual leukemic cells in autologous transplants of hematopoietic progenitor cells].

Hrkal Z, Grebenová D, Cajthamlová H, Soucek J, Bartosová J, Fuchs O, Marinov I, Kobylka P, Klamová H, Sponerová D.

Cas Lek Cesk. 2002 Sep 22;141 Suppl:41-6. Czech.

PMID:
12428422
25.

Nucleolar asynchrony observed in HL-60 leukemic granulocytic precursors resistant to 5-aminolaevulinic acid-based photodynamic treatment.

Smetana K, Cajthamlová H, Grebenová D, Jirásková I, Hrkal Z.

J Photochem Photobiol B. 2002 Jul;67(3):201-3.

PMID:
12167320
26.

Polymer conjugated bovine seminal ribonuclease inhibits growth of solid tumors and development of metastases in mice.

Soucek J, Poucková P, Zadinová M, Hlousková D, Plocová D, Strohalm J, Hrkal Z, Oleár T, Ulbrich K.

Neoplasma. 2001;48(2):127-32.

PMID:
11478693
27.

The 5-aminolaevulinic acid-based photodynamic effects on nuclei and nucleoli of HL-60 leukemic granulocytic precursors.

Smetana K, Cajthamlová H, Grebenová D, Hrkal Z.

J Photochem Photobiol B. 2000 Dec;59(1-3):80-6.

PMID:
11332894
28.

Involvement of HxuC outer membrane protein in utilization of hemoglobin by Haemophilus influenzae.

Cope LD, Love RP, Guinn SE, Gilep A, Usanov S, Estabrook RW, Hrkal Z, Hansen EJ.

Infect Immun. 2001 Apr;69(4):2353-63.

29.

Accumulation of protoporphyrin-IX (PpIX) in leukemic cell lines following induction by 5-aminolevulinic acid (ALA).

Bartosová J, Hrkal Z.

Comp Biochem Physiol C Toxicol Pharmacol. 2000 Jul;126(3):245-52.

PMID:
11048674
30.

Genes involved in the destruction of leukaemic cells by induced photosensitivity.

Belicková M, Bruchová H, Cajthamlová H, Hrkal Z, Brdicka R.

Folia Biol (Praha). 2000;46(4):131-5.

PMID:
10954157
31.

Protein changes in HL60 leukemia cells associated with 5-aminolevulinic acid-based photodynamic therapy. Early effects on endoplasmic reticulum chaperones.

Grebenová D, Halada P, Stulík J, Havlícek V, Hrkal Z.

Photochem Photobiol. 2000 Jul;72(1):16-22.

PMID:
10911724
33.

[Selective photodynamic destruction of leukemic cells].

Hrkal Z, Cajthamlová H, Grebenová D, Bartosová J, Klamová H, Marinov J.

Cas Lek Cesk. 2000 Mar 15;139(5):148-54. Czech.

PMID:
10838736
34.

The effects of heme-binding proteins on the peroxidative and catalatic activities of hemin.

Grinberg LN, O'Brien PJ, Hrkal Z.

Free Radic Biol Med. 1999 Jul;27(1-2):214-9.

PMID:
10443938
35.

Selective destruction of leukaemic cells by photo-activation of 5-aminolaevulinic acid-induced protoporphyrin-IX.

Grebenová D, Cajthamlová H, Bartosová J, Marinov J, Klamová H, Fuchs O, Hrkal Z.

J Photochem Photobiol B. 1998 Nov;47(1):74-81.

PMID:
10052155
36.
37.

Kinetics of heme interaction with heme-binding proteins: the effect of heme aggregation state.

Kuzelová K, Mrhalová M, Hrkal Z.

Biochim Biophys Acta. 1997 Oct 20;1336(3):497-501.

PMID:
9367177
38.

Photodynamic effects of meso-tetra (4-sulfonatophenyl)porphine on human leukemia cells HEL and HL60, human lymphocytes and bone marrow progenitor cells.

Grebenová D, Cajthamlová H, Holada K, Marinov J, Jirsa M, Hrkal Z.

J Photochem Photobiol B. 1997 Jul;39(3):269-78.

PMID:
9253201
39.

Haemopexin and uptake of haem by liver cells.

Bonkovsky HL, Gildemeister OS, Pepe JA, Lambrecht RW, Hrkal Z.

Eur J Clin Chem Clin Biochem. 1996 Nov;34(11):931-2. No abstract available.

PMID:
8960469
40.

Identification of an outer membrane protein involved in utilization of hemoglobin-haptoglobin complexes by nontypeable Haemophilus influenzae.

Maciver I, Latimer JL, Liem HH, Muller-Eberhard U, Hrkal Z, Hansen EJ.

Infect Immun. 1996 Sep;64(9):3703-12.

41.

[Photobiologic effects of porphyrins and their use in therapy of tumors].

Hrkal Z, Klamová H.

Cas Lek Cesk. 1996 Apr 17;135(8):236-8. Review. Czech.

PMID:
8689661
42.

Hyaluronan-binding properties of human serum hemopexin.

Hrkal Z, Kuzelová K, Muller-Eberhard U, Stern R.

FEBS Lett. 1996 Mar 25;383(1-2):72-4.

43.

[Disorders of anticoagulation and fibrinolysis in monoclonal gammopathies--another mechanism of paraprotein interference with hemostasis].

Spicka I, Cieslar P, Hrkal Z, Fortová H, Simonianová E, Zounar R, Klener P.

Sb Lek. 1996;97(3):369-75. Czech.

PMID:
9235617
44.

Differential expression of nuclear HMG1, HMG2 proteins and H1(zero) histone in various blood cells.

Cabart P, Kalousek I, Jandová D, Hrkal Z.

Cell Biochem Funct. 1995 Jun;13(2):125-33.

PMID:
7758147
45.

Roles of heme iron-coordinating histidine residues of human hemopexin expressed in baculovirus-infected insect cells.

Satoh T, Satoh H, Iwahara S, Hrkal Z, Peyton DH, Muller-Eberhard U.

Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8423-7. Erratum in: Proc Natl Acad Sci U S A 1994 Nov 8;91(23):11281.

46.

Binding of meso-tetra(4-sulfonatophenyl)porphine to haemopexin and albumin studied by spectroscopy methods.

Bartosová J, Kalousek I, Hrkal Z.

Int J Biochem. 1994 May;26(5):631-7.

PMID:
8005348
47.

Monoclonal antibodies against human hemopexin and their application.

Hrkal Z, Cajthamlová H, Kalousek I, Bartosová J.

J Immunol Methods. 1993 May 26;161(2):265-8.

PMID:
8505555
48.

[Antithrombin III. Structure, pathophysiology, determination and therapeutic importance].

Hrkal Z, Vorlová Z.

Cas Lek Cesk. 1992 Dec 4;131(24-25):749-53. Review. Czech.

PMID:
1288878
49.

Isolation of human haemopexin in apo-form by chromatography on S-Sepharose Fast Flow and Blue Sepharose CL-6B.

Hrkal Z, Cabart P, Kalousek I.

Biomed Chromatogr. 1992 Jul-Aug;6(4):212-4. No abstract available.

PMID:
1643392
50.

Monoclonal antibodies against human antithrombin III.

Hrkal Z, Cajthamlová H, Novák JT, Paluska E, Stöckbauer P.

Hybridoma. 1991 Oct;10(5):633-40.

PMID:
1804774

Supplemental Content

Support Center